NCT03277209 2020-03-02To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal AdenocarcinomasWeill Medical College of Cornell UniversityPhase 1 Terminated2 enrolled